BIOLOGICAL EFFECTS OF 1,24,25-TRIHYDROXYVITAMIN-D3 IN MAN

BIOLOGICAL EFFECTS OF 1,24,25-TRIHYDROXYVITAMIN-D3 IN MAN

Detalhes bibliográficos
Main Authors:	Cundy, T, Kanis, J, Paton, S, Smith, R, Warner, G, Bartlett, M, Russell, R
Formato:	Journal article
Publicado em:	1979

Registos relacionados

Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
Por: Kanis, J, et al.
Publicado em: (1978)

Effects of 24,25-dihydroxy-vitamin D3 on its plasma level in man.
Por: Kanis, J, et al.
Publicado em: (1981)

EVIDENCE FOR A DIRECT EFFECT OF 24,25-DIHYDROXYCHOLECALCIFEROL ON INTESTINAL-ABSORPTION OF CALCIUM
Por: Cundy, T, et al.
Publicado em: (1978)

SC and IAP Meeting for MQA/FA12425 Program Compliance Assessment Feedbacks
Por: Siti Zanariah, Satari
Publicado em: (2023)

Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
Por: Henderson, R, et al.
Publicado em: (1974)

Effects of vitamin D metabolites and analogues on renal function.
Por: Naik, R, et al.
Publicado em: (1981)

CALCITONIN, BONE-DISEASE, AND CHRONIC RENAL-FAILURE
Por: Cundy, T, et al.
Publicado em: (1978)

Preparation of [24,25-3H] cholesterol. Oxidation in man as a measure of bile acid formation.
Por: R S Rosenfeld, et al.
Publicado em: (1978-09-01)

VITAMIN-D IN CHRONIC RENAL-FAILURE
Por: Kanis, J, et al.
Publicado em: (1979)

Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
Por: Kanis, J, et al.
Publicado em: (1979)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
Por: Russell, R, et al.
Publicado em: (1979)

THE PATHO-PHYSIOLOGY OF HYPERCALCEMIA
Por: Kanis, J, et al.
Publicado em: (1980)

Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3.
Por: Karen van der Meijden, et al.
Publicado em: (2014-01-01)

Serum 25-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 concentrations in adult dogs are more substantially increased by oral supplementation of 25-hydroxyvitamin D3 than by vitamin D3
Por: Lauren R. Young, et al.
Publicado em: (2017-01-01)

Effects of 1,25-Vitamin D3 and 24,25-Vitamin D3 on Corneal Nerve Regeneration in Diabetic Mice
Por: Xiaowen Lu, et al.
Publicado em: (2023-12-01)

Physiological and therapeutic differences between vitamin D, its metabolites and analogues.
Por: Kanis, J, et al.
Publicado em: (1977)

Physiological and therapeutic differences between vitamin D, its metabolites and analogues
Por: Kanis, J, et al.
Publicado em: (1977)

Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
Por: Walton, R, et al.
Publicado em: (1974)

VITAMIN-DS, MINERALS AND RENAL BONE-DISEASE
Por: Kanis, J, et al.
Publicado em: (1979)

Osteomalacia in renal disease.
Por: Kanis, J, et al.
Publicado em: (1980)

Simultaneous Quantification of 25-Hydroxyvitamin D3 and 24,25-Dihydroxyvitamin D3 in Rats Shows Strong Correlations between Serum and Brain Tissue Levels
Por: Ying Xue, et al.
Publicado em: (2015-01-01)

Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
Por: Kanis, J, et al.
Publicado em: (1977)

Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone disease.
Por: Kanis, J, et al.
Publicado em: (1977)

Biology of man /
Por: 461467 Fox, Dennis
Publicado em: (1971)

2,5-Diphenylpenta-2,4-dienenitrile
Por: R. Archana, et al.
Publicado em: (2009-11-01)

The vitamin D's in chronic renal failure
Por: Kanis, J, et al.
Publicado em: (1979)

THERAPEUTIC ADVANTAGE OF 1-ALPHA-HYDROXYLATED COMPOUNDS OVER VITAMIN-D
Por: Kanis, J, et al.
Publicado em: (1977)

The First Convergent Synthesis of 23,23-Difluoro-25-hydroxyvitamin D<sub>3</sub> and Its 24-Hydroxy Derivatives: Preliminary Assessment of Biological Activities
Por: Sayuri Mototani, et al.
Publicado em: (2022-08-01)

[24,25-3H]Cholesterol: presence of tritium at additional sites in the side chain
Por: R S Rosenfeld, et al.
Publicado em: (1983-06-01)

Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair
Por: Corine Martineau, et al.
Publicado em: (2020-07-01)

(20S)-24,25-Dihydroxy-20,24-epoxy-3,4-secodammar-4(28)-en-3-oic acid from Aglaia smithii
Por: Harneti, D., et al.
Publicado em: (2010)

2nd Annual Osteoporosis Expert Forum - November 24-25, 2006 - Valencia, Spain - Abstracts
Por: Russell, G
Publicado em: (2007)

Preparation of 24(R)- and 24(S)-5β-cholestane-3α,7α,24-triols and 25(R)- and 25(S)-5β-cholestane-3α,7α,26-triols by a hydroboration procedure
Por: B Dayal, et al.
Publicado em: (1978-02-01)

Quantitative NMR (qNMR) spectroscopy based investigation of the absolute content, stability and isomerization of 25-hydroxyvitamin D2/D3 and 24(R),25-dihydroxyvitamin D2 in solution phase
Por: Neeraj Singh, et al.
Publicado em: (2022-02-01)

2.5D Visualisation of Overlapping Biological Networks
Por: Fung David C.Y., et al.
Publicado em: (2008-03-01)

2.5D Visualisation of Overlapping Biological Networks
Por: Fung David C.Y., et al.
Publicado em: (2008-03-01)

Effects of Topical 1,25 and 24,25 Vitamin D on Diabetic, Vitamin D Deficient and Vitamin D Receptor Knockout Mouse Corneal Wound Healing
Por: Xiaowen Lu, et al.
Publicado em: (2023-07-01)

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
Por: Walton, R, et al.
Publicado em: (1975)

Reproducibility of 24-hour serum growth hormone profiles in man.
Por: Saini, S, et al.
Publicado em: (1991)

The Long, Long Day : Homage to the Le Mans 24 Hours /
Por: Nissan Motor 546901
Publicado em: (1987)